Glanbia plc is a global nutrition group, grounded in nature and science, dedicated to providing better nutrition for every step of life’s journey.
Today’s consumers are increasingly aware of the importance of nutrition in improving their overall health and wellbeing. They are searching for better, healthier and smarter nutritional solutions that fit their lifestyles.
Glanbia takes pure and clean ingredients including milk, whey and grains, and using our expert knowledge and capabilities we produce high-quality nutritional ingredients and branded consumer products for our customers and consumers worldwide.
We employ over 6,000 people across 32 countries and our products are sold or distributed in over 130 countries with an annual turnover of €3.6 billion. Our major production facilities are located in Ireland, the US, the UK, Germany and China.
We have four segments:
Glanbia delivered a strong performance in 2016. Wholly owned revenue was €2,847.9 million, an increase of 2.8% constant currency (up 2.7% reported). Wholly owned EBITA was €305.1 million, up 12.5% constant currency (up 12.6% reported). Wholly owned EBITA margin was 10.7%, up 90 bps, constant currency and reported. Total Group revenue for the period, including the Group’s share of Joint Ventures & Associates, was €3,697.0 million, an increase of 1.3% constant currency (up 0.8% reported). Total Group EBITA was €349.8 million, up 12.8% constant currency (up 12.6% reported). Total Group EBITA margin was 9.5%, up 100 bps, constant currency and reported. Adjusted earnings per share for the year were 87.66 cent, up 11.2%, constant currency (up 10.8% reported).
On a pro-forma* basis Glanbia expects the adjusted EPS of the continuing Group to grow between 7% - 10% constant currency in 2017. The Dairy Ireland transaction is expected to be 5%-7% adjusted EPS dilutive in a full-year. Growth in 2017 is expected to be more evenly balanced across Glanbia Performance Nutrition (GPN) and Glanbia Nutritionals (GN). GPN growth will be driven by organic brand development and innovation as well as a contribution from recent acquisitions. GPN expects like-for-like branded revenues to grow in the mid-single digit range with EBITA margins expected to be in the mid-teen range. GN expects EBITA growth in 2017 to be driven by continued growth in the value added portfolio of Nutritional Solutions.